Epileptik Bir Çocukta Amanita Virosa Alımı Sonrası Refrakter Status Epileptikus Oluşması
Abstract
Keywords
References
- Brophy GB, Bell R, Alldredge A, Bleck TP, Claassen J, LaRoche SM, et al. Neurocritical Care Society Status Epilepticus Guideline Neurocrit Care Writing Committee. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 2012; 17: 3-23. [CrossRef]
- Mayer SA, Claassen J, Lokin J, Mendelsohn F, Dennis LJ, Fitzsimmons BF. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol 2002; 59: 205-10. [CrossRef]
- Kohn R, Mot’ovska Z. Mushroom poisoning: classification, symptoms and therapy. Vnitrni lekarstvi 1997; 43: 230-33.
- Riviello JJ Jr, Claassen J, LaRoche SM, Sperling MR, Allredge B, Bleck TP et al. Treatment of status epilepticus: an international survey of experts. Neurocrit Care 2013; 18: 193-200. [CrossRef]
- Piering WF, Bratanow N. Role of the clinical laboratory in guiding treatment of Amanita virosa mushroom poisoning: report of two cases. Clinical Chemistry 1990;36: 571-74.
- Enjalbert F, Rapior S, Nouguier-Soulé J, Guillon S, Amouroux N, Cabot C. Treatment of amatoxin poisoning: 20-Year retrospective analysis. J Toxicol Clin Toxicol 2002; 40: 715-57. [CrossRef]
- Leist M, Gantner F, Naumann H, Bluethmann H, Vogt K, Brigelius-Flohe R, et al. Tumor necrosis factor-induced apoptosis during the poisoning of mice with hepatotoxins. Gastroenterology 1997; 112: 923-34. [CrossRef]
- Wittebole X, Hantson P. Use of the molecular adsorbent recirculating system (MARS) for the management of acute poisoning with or without liver failure. Clinical Toxicology 2011; 49: 782-93. [CrossRef]
Details
Primary Language
English
Subjects
-
Journal Section
-
Authors
Ali Güneş
This is me
Halil Kocamaz
This is me
Servet Yel
This is me
Mehmet Boşnak
This is me
Publication Date
April 1, 2014
Submission Date
April 1, 2014
Acceptance Date
-
Published in Issue
Year 2014 Volume: 5 Number: 4